Cargando…
Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions
Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808455/ https://www.ncbi.nlm.nih.gov/pubmed/33466210 http://dx.doi.org/10.1097/MD.0000000000024254 |
_version_ | 1783636900802723840 |
---|---|
author | Thomas, Rohit Philip Viniol, Simon König, Alexander Marc Portig, Irene Swaid, Zaher Mahnken, Andreas H. |
author_facet | Thomas, Rohit Philip Viniol, Simon König, Alexander Marc Portig, Irene Swaid, Zaher Mahnken, Andreas H. |
author_sort | Thomas, Rohit Philip |
collection | PubMed |
description | Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automated delivery system being the latest. The aim of this study is to evaluate the safety, efficacy, and learning curve of an automated CO(2) injection system with controlled pressures in peripheral arterial interventions and also to study the patients’ tolerance to the system. From January 2018 to October 2019 peripheral arterial interventions were performed in 40 patients (median age-78 years, interquartile range: 69–84 years) using an automated CO(2) injection system with customized protocols, with conventional iodine contrast agent used only as a bailout option. The pain and tolerance during the CO(2) angiography were evaluated with a visual analog scale at the end of each procedure. The amount of CO(2), iodine contrast used, and radiation dose area product for the interventions were also systematically recorded for all procedures. These values were statistically compared in 2 groups, viz first 20 patients where a learning curve was expected vs the rest 20 patients. All procedures were successfully completed without complications. All patients tolerated the CO(2) angiography with a median total pain score of 3 (interquartile range: 3–4), with no statistical difference between the groups (P = .529). The 2 groups were statistically comparable in terms of comorbidities and the type of procedures performed (P = .807). The amount of iodine contrast agent used (24.60 ± 6.44 ml vs 32.70 ± 8.70 ml, P = .006) and the radiation dose area product associated were significantly lower in the second group (2160.74 ± 1181.52 μGym(2) vs 1531.62 ± 536.47 μGym(2), P = .043). Automated CO(2) angiography is technically feasible and safe for peripheral arterial interventions and is well tolerated by the patients. With the interventionalist becoming familiar with the technique, better diagnostic accuracy could be obtained using lower volumes of conventional iodine contrast agents and reduction of the radiation dose involved. |
format | Online Article Text |
id | pubmed-7808455 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-78084552021-01-15 Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions Thomas, Rohit Philip Viniol, Simon König, Alexander Marc Portig, Irene Swaid, Zaher Mahnken, Andreas H. Medicine (Baltimore) 6800 Carbon dioxide (CO(2)) gas is an established alternative to iodine contrast during angiography in patients with risk of postcontrast acute kidney injury and in those with history of iodine contrast allergy. Different CO(2) delivery systems during angiography are reported in literature, with automated delivery system being the latest. The aim of this study is to evaluate the safety, efficacy, and learning curve of an automated CO(2) injection system with controlled pressures in peripheral arterial interventions and also to study the patients’ tolerance to the system. From January 2018 to October 2019 peripheral arterial interventions were performed in 40 patients (median age-78 years, interquartile range: 69–84 years) using an automated CO(2) injection system with customized protocols, with conventional iodine contrast agent used only as a bailout option. The pain and tolerance during the CO(2) angiography were evaluated with a visual analog scale at the end of each procedure. The amount of CO(2), iodine contrast used, and radiation dose area product for the interventions were also systematically recorded for all procedures. These values were statistically compared in 2 groups, viz first 20 patients where a learning curve was expected vs the rest 20 patients. All procedures were successfully completed without complications. All patients tolerated the CO(2) angiography with a median total pain score of 3 (interquartile range: 3–4), with no statistical difference between the groups (P = .529). The 2 groups were statistically comparable in terms of comorbidities and the type of procedures performed (P = .807). The amount of iodine contrast agent used (24.60 ± 6.44 ml vs 32.70 ± 8.70 ml, P = .006) and the radiation dose area product associated were significantly lower in the second group (2160.74 ± 1181.52 μGym(2) vs 1531.62 ± 536.47 μGym(2), P = .043). Automated CO(2) angiography is technically feasible and safe for peripheral arterial interventions and is well tolerated by the patients. With the interventionalist becoming familiar with the technique, better diagnostic accuracy could be obtained using lower volumes of conventional iodine contrast agents and reduction of the radiation dose involved. Lippincott Williams & Wilkins 2021-01-15 /pmc/articles/PMC7808455/ /pubmed/33466210 http://dx.doi.org/10.1097/MD.0000000000024254 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) |
spellingShingle | 6800 Thomas, Rohit Philip Viniol, Simon König, Alexander Marc Portig, Irene Swaid, Zaher Mahnken, Andreas H. Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title | Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title_full | Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title_fullStr | Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title_full_unstemmed | Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title_short | Feasibility and safety of automated CO(2) angiography in peripheral arterial interventions |
title_sort | feasibility and safety of automated co(2) angiography in peripheral arterial interventions |
topic | 6800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808455/ https://www.ncbi.nlm.nih.gov/pubmed/33466210 http://dx.doi.org/10.1097/MD.0000000000024254 |
work_keys_str_mv | AT thomasrohitphilip feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions AT viniolsimon feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions AT konigalexandermarc feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions AT portigirene feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions AT swaidzaher feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions AT mahnkenandreash feasibilityandsafetyofautomatedco2angiographyinperipheralarterialinterventions |